Dectin-1 signaling in neutrophils up-regulates PD-L1 and triggers ROS-mediated suppression of CD4+ T cells
Journal of Leukocyte Biology · 25.11.2022 · 112 (6) · 1413-1425
DOI: 10.1002/jlb.3a0322-152rr ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 08.09.2022. Verfasst von M Elizabeth Deerhake und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Neutrophils, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Dectin-1 is known to drive proinflammatory cytokine production by macrophages and dendritic cells which promotes Th17 CD4+ T cell responses in the setting of fungal infection. However, the role of Dectin-1 signaling in neutrophils and its impact on CD4+ T cells is not well understood. In this study, we found that neutrophils stimulated with a Dectin-1 agonist diminish CD4+ T cell viability in a rapid and reactive oxygen species (ROS)-dependent manner. Furthermore, Dectin-1 promoted neutrophil PD-L1 expression via Syk and Card9 signaling, along with other immune-checkpoint factors in a neutrophil-biased manner. Although neutrophil PD-L1 did not significantly impact disease severity in experimental autoimmune encephalomyelitis (EAE), we found that CNS-infiltrated neutrophils potently up-regulate PD-L1 expression. Furthermore, a subset of PD-L1+ neutrophils was also found to express MHC-II during EAE. In summary, we found that Dectin-1 elicits a biphasic neutrophil response in which (1) T-cell suppressive ROS is followed by (2) up-regulation of PD-L1 expression. This response may serve to limit excess CD4+ T cell-driven inflammation in infection or autoimmunity while preserving host-defense functions of neutrophils. Summary sentence: Mechanisms by which Dectin-1 signaling in neutrophils promotes a cellular phenotype with T cell-suppressive properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.
- Tri-Institutional MD-PhD Program, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.
ORCID-Profile: M Elizabeth Deerhake
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
Zitieren
APA
Deerhake, M. E., Cardakli, E. D., & Shinohara, M. L. (2022). Dectin-1 signaling in neutrophils up-regulates PD-L1 and triggers ROS-mediated suppression of CD4+ T cells. Journal of Leukocyte Biology, 112(6), 1413-1425. https://doi.org/10.1002/jlb.3a0322-152rr
Vancouver
Deerhake ME, Cardakli ED, Shinohara ML. Dectin-1 signaling in neutrophils up-regulates PD-L1 and triggers ROS-mediated suppression of CD4+ T cells. Journal of Leukocyte Biology. 2022;112(6):1413-1425. doi:10.1002/jlb.3a0322-152rr
BibTeX
@article{Deerhake2022,
author = {Deerhake, M Elizabeth and Cardakli, Emre D and Shinohara, Mari L},
title = {Dectin-1 signaling in neutrophils up-regulates PD-L1 and triggers ROS-mediated suppression of CD4+ T cells},
journal = {Journal of Leukocyte Biology},
year = {2022},
volume = {112},
number = {6},
pages = {1413--1425},
doi = {10.1002/jlb.3a0322-152rr}
}
EUVIMED